SG Americas Securities, LLC - ALNYLAM PHARMACEUTICALS INC ownership

ALNYLAM PHARMACEUTICALS INC's ticker is and the CUSIP is 02043Q957. A total of 6 filers reported holding ALNYLAM PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of ALNYLAM PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$129,000
-42.7%
32,200
+40.6%
0.00%
-50.0%
Q1 2018$225,00022,9000.00%
Other shareholders
ALNYLAM PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
PURA VIDA INVESTMENTS, LLC 50,000$7,293,0000.42%
GROUP ONE TRADING, L.P. 160,100$23,351,0000.04%
JANE STREET GROUP, LLC 271,600$39,613,0000.02%
SIMPLEX TRADING, LLC 20,600$3,004,0000.00%
Twin Tree Management, LP 3,600$525,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
JPMORGAN CHASE & CO 11,900$1,736,0000.00%
View complete list of ALNYLAM PHARMACEUTICALS INC shareholders